Diversity, Equity & Inclusion

The Association of Molecular Pathology (AMP)’s mission is to enable the highest quality healthcare by advancing the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy. We believe diversity, equity, and inclusion (DEI) is crucial to our efforts to serve our members and advance clinical care of patients. DEI will help ensure the long-term excellence of both the association and field of molecular and genomic laboratory medicine. At AMP, we define diversity, equity, and inclusion as:


means all the ways that people are unique, which goes beyond gender to include race and ethnicity, sexual orientation, gender identity, age, religion, culture identity, disability, national origin, geographic location, scientific specialty and experience.


creates fair treatment and access for individuals by establishing policies and processes that both break down existing barriers and prevent the formation of new barriers for the success of members and staff, those they train and mentor, and ultimately the patients whom molecular and genomic laboratory medicine service.


fosters an environment where all members and staff participate fully and are their authentic selves in their local work environment because they feel respected and valued.


Our community consists of healthcare professionals who are committed to helping people. Our field is best served by amplifying diverse voices in our community and including representation from across the spectrum of our community in everything we do. We will work together collaboratively across the healthcare field to address inequities for patients.

DEI is embedded within our core principles:

  • Quality Health Care Through Excellence in Clinical Molecular Testing
  • Fostering a Diverse and Inclusive Global Community of Molecular Pathology Professionals
  • Collaboration to Advance Molecular Pathology and Improve Equity in the Delivery of Molecular Laboratory Testing
  • Advocacy that Advances the Field and Practice of Molecular Pathology, Protects Patients, and Improves the Adoption of Innovative Technologies and Tests
  • Innovation to Transform Patient Care

In March 2022, AMP’s Board of Directors approved a new DEI Commitment and approved revisions to our Core Principles, which guide everything we do at AMP.  

AMP DEI aims can be summarized as follows:

1)  Enhance DEI at AMP (identify & address barriers to involvement or leadership, improve opportunities for members and staff, and more).
2)   Provide resources to help members improve DEI at their institutions.
3)  Promote a diverse, equitable and inclusive next generation of molecular professionals through training + opportunities within AMP, and resources that members can use at their institutions.






Corporate Partners